Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neurodegeneration biomarkers and longitudinal studies

Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.

Ming-Liang Wang; Qiao-Qiao Zou; Zheng Sun; Xiao-Er Wei; Peng-Yang Li; Xue Wu; Yue-Hua Li; Alzheimer’s Disease Neuroimaging Initiative

Originally published in Alzheimer's research & therapy · 2022-12-13

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Objective To investigate the characteristics and associations of MRI-visible perivascular spaces (PVS) with clinical progression and longitudinal cognitive decline across the Alzheimer's disease spectrum. Methods We included 1429 participants (641 [44.86%] female) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. PVS number and grade in the centrum semiovale (CSO-PVS), basal ganglia (BG-PVS), and hippocampus (HP-PVS) were compared among the control (CN), mild cognitive impairment (MCI), and Alzheimer's disease (AD) groups. PVS were tested as predictors of diagnostic progression (i.e., CN to MCI/AD or MCI to AD) and longitudinal changes in the 13-item Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog 13), Mini-Mental State Examination (MMSE), memory (ADNI-MEM), and executive function (ADNI-EF) using multiple linear regression, linear mixed-effects, and Cox proportional hazards modeling. Results Compared with CN subjects, MCI and AD subjects had more CSO-PVS, both in number (p 0.05).

Discussion

In this study, we investigated the characteristics and associations of MRI-visible PVS with clinical progression and longitudinal cognitive decline across the AD spectrum. Our study found that MCI and AD subjects had more CSO-PVS than CN subjects. Individuals with moderate and frequent/severe grade CSO-PVS had a more than 2-fold higher clinical progression risk than individuals with no/mild grade CSO-PVS. A higher CSO-PVS number was associated with baseline cognitive performance and longitudinal cognitive decline in all cognitive tests.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?